Purchase Order N6311623P0568
- Not listed
- This is a sole-source firm fixed-price purchase order awarded by the U.S. Navy Bureau of Medicine and Surgery (BUMED) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a contract titled "ESSENTIAL CARE - XPRESS 4X2 1Y CONTRACT". The contract has a total ceiling value of $88,055.00 and a period of performance from September 26, 2022 to September 25, 2027, with four one-year option periods. The contract is for the maintenance and support of Cepheid GeneXpert...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Navy, to Cepheid Inc. for the provision of GeneXpert IV-2 CLIA diagnostic systems, printers, and associated equipment and services. The $79,625 contract award does not have a set-aside designation, as Cepheid was selected as the sole-source provider. The contract supports the Naval Health Research Center's (NHRC) requirement for molecular diagnostic equipment and consumables...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a CEPHEID GENEXPERT LABORATORY SYSTEMS SERVICE AGREEMENT AND PREVENTIVE MAINTENANCE contract. The contract has a ceiling value of $78,830.00 and an ultimate completion date of January 31, 2029. The contract does not have a set-aside designation. Cepheid, the prime contractor, specializes in advanced diagnostic systems and test kits for...
- This federal contract award, with a value of $92,170.00, was made by the Bureau of Medicine and Surgery (BUMED) of the U.S. Navy to Cepheid, a subsidiary of Danaher Corporation. The contract is for the delivery of a GeneXpert IV-4 site system, a black and white printer, and related services and maintenance for one year. This sole-source contract was awarded under the XPRSARS-COV2-10 requirement, which supports the Navy's laboratories at the Naval Health Research Center (NHRC) in San Diego. The...
- This is a $133,347.84 firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for CEPHEID GENEXPERT SERVICE MAINTENANCE. The contract has an ultimate completion date of March 6, 2026 and was awarded on March 7, 2022. There is no set-aside designation noted for this contract. The original solicitation requested pricing for the GeneXpert diagnostic system maintenance services. Cepheid is a key federal...
- This is a $76,200.00 firm fixed-price purchase order contract awarded by the U.S. Department of the Navy's Bureau of Medicine and Surgery to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for INFINITY 48-48 ADVANTAGE SERVICE and does not have a set-aside designation. Cepheid is a subsidiary of Danaher Corporation, a global science and technology company that has been awarded numerous federal contracts and grants to supply critical components and services...
- This is a firm fixed-price purchase order contract awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for a service agreement to provide GeneXpert diagnostic equipment, reagents, consumables, and associated maintenance and support services. The contract has a ceiling value of $16,492.68 and a performance period ending on July 31, 2024. Cepheid has been awarded numerous prime federal contracts and indefinite-delivery vehicles (IDVs)...
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center, a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The $107,336.00 contract is for preventative maintenance agreements covering two GeneXpert system modules (GX16-12 and GX4-4) used in the Microbiology Service's Department of Laboratory Medicine. The contract has a base year from August 8, 2025 to August 7, 2026, with three...
- The Defense Health Agency awarded a purchase order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on October 1, 2025, for repair and preventive maintenance services on government-owned Cepheid diagnostic devices at Naval Medical Center San Diego. This firm fixed-price purchase order, with no set-aside designation, carries a ceiling value of $117,775 and extends through September 30, 2030. Cepheid, headquartered in Sunnyvale, California, is a leading manufacturer of advanced molecular diagnostic systems,...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the service and repair of the Cepheid GeneXpert IV and GeneXpert XVI analyzer machines, as Cepheid is the sole manufacturer and trainer of authorized technicians. The contract has a ceiling value of $165,112.00 and a period of performance that runs from the award date of July 16, 2024 to the...
This is a sole-source firm-fixed-price purchase order contract awarded by the U.S. Navy's Bureau of Medicine and Surgery (BUMED) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract is for the maintenance of a Cepheid GeneXpert Infinity 48-48 System located at the Naval Health Research Center (NHRC) laboratory in San Diego, California. The base year of performance is from August 28, 2023, to August 27, 2024, with an optional one-year extension from August 28, 2024, to August 27, 2025. The contract ceiling value is $89,034.00 and includes 24/7 phone support, onsite support, annual preventative maintenance, parts, labor, travel, software upgrades, and a 98% uptime guarantee. This contract does not have a set-aside designation.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Infinity 48-48 Maintenance | N63116-23-Q-0568 | Department of the Navy Naval Supply Systems Command | Special Notice 1/1 | 7/26/23, 1:34 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.3k | 8/15/23 |